CaliPharms Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2013	FY 2012	FY 2012	FY 2011	FY 2010
Period Ending	Sep '14 Sep 30, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012	Jun '12 Jun 30, 2012	Jun '11 Jun 30, 2011	Jun '10 Jun 30, 2010
Revenue	0.11	-	-	-	-	-
Cost of Revenue	0.14	-	-	-	-	-
Gross Profit	-0.03	-	-	-	-	-
Selling, General & Admin	0.75	0.21	0.81	0.67	1.25	0.83
Operating Expenses	0.75	0.21	0.81	0.67	1.25	0.83
Operating Income	-0.78	-0.21	-0.81	-0.67	-1.25	-0.83
Interest Expense	-2.45	-0	-0.1	-0.33	-0.33	-0.88
Other Non Operating Income (Expenses)	-2.71	-	-	-	-	-1.64
EBT Excluding Unusual Items	-5.93	-0.22	-0.92	-1.01	-1.57	-3.35
Asset Writedown	-0.38	-	-	-	-	-
Pretax Income	-6.31	-0.22	-0.92	-1.01	-1.57	-3.35
Earnings From Continuing Operations	-6.31	-0.22	-0.92	-1.01	-1.57	-3.35
Earnings From Discontinued Operations	-	-	-	-0.02	-	-2.61
Net Income	-6.31	-0.22	-0.92	-1.03	-1.57	-5.96
Net Income to Common	-6.31	-0.22	-0.92	-1.03	-1.57	-5.96
Shares Outstanding (Basic)	3,363	40	10	4	3	2
Shares Outstanding (Diluted)	3,363	40	10	4	3	2
Shares Change (YoY)	31942.59%	285.84%	150.09%	32.66%	94.34%	465.65%
EPS (Basic)	-0.00	-0.01	-0.09	-0.24	-0.50	-3.66
EPS (Diluted)	-0.00	-0.01	-0.09	-0.24	-0.50	-3.66
Free Cash Flow	-0.72	-0.05	-0	-0.21	-0.14	-0.59
Free Cash Flow Per Share	-	-0.00	-	-0.05	-0.04	-0.36
Gross Margin	-27.18%	-	-	-	-	-
Operating Margin	-689.66%	-	-	-	-	-
Profit Margin	-5612.48%	-	-	-	-	-
Free Cash Flow Margin	-641.48%	-	-	-	-	-
EBITDA	-	-	-	-	-	-0.81
D&A For EBITDA	-	-	-	-	-	0.02
EBIT	-0.78	-0.21	-0.81	-0.67	-1.25	-0.83

Source: S&P Global Market Intelligence. Standard template. Financial Sources.